The randomised, double-blind, placebo-controlled study enrolled 2,339 adults with obesity or overweight and at least one weight-related health condition (such as high blood pressure or heart disease) but without diabetes
Common adverse effects associated with GLP-1 medications are predominantly gastrointestinal in nature
Verified reviewer I recently moved to a smaller city in British Columbia
You get the best of both worlds: a slimmer body and a refreshed, youthful face
tirzepatides fatty-acid tail lets it bind albumin and circulate for roughly five days, which is why a single weekly injection maintains steady receptor engagement
Rapid heart rate or palpitations Any changes to heart rate that are new or worsening after starting GLP-1 treatment are worth reporting to a doctor, particularly for patients with existing cardiac conditions